Rigenerand Competitors and Similar CompaniesClear all

Rigenerand's competitors and similar companies include Fusion Pharmaceuticals, Shoreline Biosciences and TScan Therapeutics.

	Rigenerand Rigenerand is a company offering products for clinical applications of cell-based technologies for regenerative medicine and oncology.	Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.	Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.	TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
Founding Date	Founding Date 2009	Founding Date 2014	Founding Date 2020	Founding Date 2018
Type	Type Private	Type Subsidiary	Type Private	Type Public
Tags	Tags Technology biotech oncology pharma	Tags Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy
Locations	Locations Medolla, IT HQ	Locations Hamilton, CA HQ Boston, US	Locations San Diego, US HQ San Diego, US	Locations Waltham, US HQ
Employees	Employees 5	Employees 101	Employees 4716% decrease	Employees 7316% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2.1m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $10.3m (FY, 2025)
Net income	Net income N/A	Net income ($94.9m) (FY, 2023)	Net income N/A	Net income ($129.8m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 9.9m (about 10 years ago)	Latest funding round N/A	Latest funding round $ 43m (about 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 9.9m	Total funding raised $ 170.9m	Total funding raised $ 46m	Total funding raised $ 137.5m